Show simple item record

Exploring the use of cold atmospheric plasma to overcome drug resistance in cancer

dc.contributor.authorMurillo, Dzohara
dc.contributor.authorHuergo, Carmen
dc.contributor.authorGallego, Borja
dc.contributor.authorRodríguez González, René 
dc.contributor.authorTornin, Juan
dc.date.accessioned2023-05-18T08:20:30Z
dc.date.available2023-05-18T08:20:30Z
dc.date.issued2023
dc.identifier.citationBiomedicines, 11(1) (2023); doi:10.3390/biomedicines11010208
dc.identifier.issn2227-9059
dc.identifier.urihttp://hdl.handle.net/10651/67957
dc.description.sponsorshipAuthors acknowledge the financial support of Fundación Alimerka (2022-052-ALIMERKA-TOCAJ), and the Asociación de niños con cancer Galbán de Asturias (grant 2022-101-GALBAN_TOCAJ to JT and RR) and Severo Ochoa predoctoral fellowships (BP-20-046 to B.G. and BP-21-084 to DM).
dc.language.isoeng
dc.relation.ispartofBiomedicines
dc.rights© 2023 by the authors.
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceWOS:000916727500001
dc.titleExploring the use of cold atmospheric plasma to overcome drug resistance in cancer
dc.typejournal article
dc.identifier.doi10.3390/biomedicines11010208
dc.relation.projectIDBP-20-046
dc.relation.projectIDBP-21-084
dc.relation.publisherversionhttp://dx.doi.org/10.3390/biomedicines11010208
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Files in this item

untranslated

This item appears in the following Collection(s)

Show simple item record

© 2023 by the authors.
This item is protected with a Creative Commons License